Evidence map›Paper›PMID 27269588›Full record

ArticleJournal of virological methods2016

Removal of nuclease contamination during purification of recombinant prototype foamy virus integrase.

Miguel A Lopez, Randi M Mackler, Kristine E Yoder

Abstract read
In one paragraph

Article in Journal of virological methods, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Foamy Virus Integrase in Development of Viral Vector for Gene Therapy.Journal of microbiology and biotechnology · 2020
    Review
  4. Article
  5. Article
  6. Prototype foamy virus integrase is promiscuous for target choice.Biochemical and biophysical research communications · 2018
    Article
  7. Assembly and Purification of Prototype Foamy Virus Intasomes.Journal of visualized experiments : JoVE · 2018
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Miguel A LopezMolecular Virology, Immunology, and Medical Genetics, The Ohio State University College of Medicine, Columbus, OH 43210, United States.
Randi M MacklerMolecular Virology, Immunology, and Medical Genetics, The Ohio State University College of Medicine, Columbus, OH 43210, United States.
Kristine E YoderMolecular Virology, Immunology, and Medical Genetics, The Ohio State University College of Medicine, Columbus, OH 43210, United States. Electronic address: yoder.176@osu.edu.
The Ohio State University · US

Funding

Studies of the molecular mechanism of retroviral integrationR21AI099854 · NIAID · OHIO STATE UNIVERSITY · PI FISHEL, RICHARD, YODER, KRISTINE E · 2013 to 2014
$422k
NIAID NIH HHS R21 AI099854
6 · The paper itself

Abstract

Retroviral infection requires integration of the viral genome into the host genome. Recombinant integrase proteins may be purified following bacterial expression. A bulk biochemical assay of integrase function relies on the conversion of supercoiled plasmids to linear or relaxed circles. Single molecule molecular tweezer assays of integrase also evaluate the conversion of supercoiled DNA to nicked and broken species. A bacterial nuclease that co-purifies with retroviral integrase may affect the quantitation of integration activity in bulk or single molecule assays. During purification of retroviral integrase from bacteria, fractions may be screened for contaminating nuclease activity. In order to efficiently separate the nuclease from integrase, the binding affinities of each protein must differ. We find that a co-purifying nuclease may be efficiently separated from integrase based on heparin affinity, but not ionic affinity.

Indexed as

DeoxyribonucleasesChromatography, AffinityDNA, ViralHeparinIntegrasesRecombinant ProteinsSepharoseSpumavirusViral ProteinsVirus IntegrationDeoxyribonucleasesDNA, ViralHeparinIntegrasesRecombinant ProteinsSepharoseViral ProteinsIntegraseProtein purificationRetrovirus

Identifiers

PMID27269588
PMCPMC4992616
OpenAlexW2415630717

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.